Covid-19: Brazil authorizes Pfizer vaccine for children over 12 years old


The drug regulatory agency in Brazil today authorized the indication of the vaccine against covid-19 Comirnaty, by Pfizer, for children aged 12 years and over.

In a statement, the National Health Surveillance Agency (Anvisa) informed that, with this authorization, the vaccine package insert will indicate this new age group for Brazil.

“The expansion was approved after the presentation of studies developed by the laboratory that indicated the safety and efficacy of the vaccine for this group. The studies were developed outside Brazil and evaluated by Anvisa”, he highlighted.

Before, the Comirnaty vaccine was authorized in Brazil for people aged 16 or over. So far, this is the only one among the vaccines authorized in the country with an indication for children under 18 years of age.

Pfizer’s vaccine was the first to receive definitive registration for vaccines covid-19 No brazil.

Brazil is the Portuguese-speaking country most affected by the pandemic and one of the most affected in the world, accounting for 482,019 fatalities and more than 17.2 million confirmed cases of covid-19.

A pandemic of covid-19 caused at least 3,764,250 deaths in the world, resulting from more than 174.3 million cases of infection, according to a balance made by the French agency AFP.

The disease is transmitted by the new SARS-COV-2 coronavirus detected in late 2019 in Wuhan, a city in central China.


Source: Futebol 365 – Notícias by www.futebol365.pt.

*The article has been translated based on the content of Futebol 365 – Notícias by www.futebol365.pt. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!